P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
Year: 2016
Type: article
Source: Journal of Thoracic Oncology
Authors: Jonathan W. Goldman, Lucio Crino, Everett E. Vokes, Esther Holgado, Karen Reckamp, Adam Pluzanski, David Spigel, Martin Kohlhaeufl, Marina Garassino, Laura Qm Chow, Scott Gettinger, David E. Gerber, Libor Havel, Suresh S. Ramalingam, Grace K. Dy, William J. Geese, Ang Li, Anne Blackwood-Chirchir, Diane Healey, Julie Brahmer, Gilberto Lopes
Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of Perugia, University of Chicago Medical Center, Hospital Universitario HM Sanchinarro, City Of Hope National Medical Center, City of Hope, The Maria Sklodowska-Curie National Research Institute of Oncology, Tennessee Oncology, Robert Bosch Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Washington, Yale Cancer Center, The University of Texas Southwestern Medical Center, Fakultní nemocnice Bulovka, Winship Cancer Institute, Roswell Park Comprehensive Cancer Center, Bristol-Myers Squibb (United States), Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2528962190